Compared with control, treatment with RG, Mix, RG@γ-CD or RG@M-γ-CD significantly decreased the TAM population in tumor tissue (CD206+ F4/80+ subset gated on CD45+ set). The gene discussed is MRC1; the disease is neoplasm.